Naga Pannala in Oklahoma City, Oklahoma

Home Oklahoma Oklahoma City

Naga Pannala has Cardiovascular Disease (cardiology) as her primary medical specialty. Their primary office is: 7313 S Western Ave in Oklahoma City, Oklahoma. There is an additional office location, for a total of two, for Naga Pannala that can be viewed further down. They attended Sorry, her university is not listed and graduated in 2008 (around 16 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Naga L Pannala Office Phone and Directions

Naga Pannala
7313 S Western Ave
Oklahoma City, Oklahoma 73139
405-251-8884

Patient Ratings
Please rate your experience with Naga Pannala below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 405-251-8884

Enter a starting address:

Healthcare Info for Naga Pannala

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Sorry, her university is not listed
Graduation Year: 2008
The Primary Medical Specialty for Naga Pannala is listed as: Cardiovascular Disease (cardiology)
Approximate Years of Experience: 16
PAC (PECOS ID)#: 2365743556
NPI #: 1366673352
NPI Created On: 08/07/2009
NPI Last Updated Listed as: 02/16/2022
Primary Taxonomy Code: 207RC0000X
License Number:
D0080352
Listed Gender: Female

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

CareFirst BlueChoice, Inc.
Group Hospitalization and Medical Services Inc.
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

External ekg recording for more than 48 hours up to 21 days
Review and interpretation of external ekg recording for more than 48 hours up to 21 days
Nuclear medicine study of vessels of heart using drugs or exercise multiple studies
Routine ekg using at least 12 leads including interpretation and report
Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report
Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
Follow-up or limited ultrasound examination of heart
Doppler ultrasound study of heart blood flow, valves, and chambers
Doppler ultrasound study of color-directed heart blood flow, rate, and valve function
New patient office or other outpatient visit, typically 45 minutes
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Initial hospital inpatient care, typically 50 minutes per day
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day
Technetium tc-99m sestamibi, diagnostic, per study dose
Injection, regadenoson, 0.1 mg

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788161763

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788161765

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $9

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788161767

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788161771

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $2

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788161769

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $38

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788161773

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788161775

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $23

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783544579

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular

Name of Drug #1: ELIQUIS

Open Associated Drug #1: 0003-0894-31

Payments Total: $20

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783544613

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular

Name of Drug #1: ELIQUIS

Open Associated Drug #1: 0003-0894-31

Payments Total: $15

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783544661

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular

Name of Drug #1: ELIQUIS

Open Associated Drug #1: 0003-0894-31

Additional Office Locations

1.
3138 S Garnett Rd
Tulsa, OK 74146
Archwell Health Garnett Road
Group Members: 0

Phone: 405-251-8884

Enter a starting address:

Cardiovascular Disease (cardiology) Professionals in Oklahoma City

1.
Naji Karam MD

608 Nw9th St
Oklahoma-city, OK

2.
Naji Karam MD

608 Nw 9th St
Oklahoma-city, OK

3.
Naji Karam MD

608 Nw 9th St
Oklahoma-city, OK
Ssm Health Care Of Oklahoma, Inc.

4.
Naji Karam MD

1000 N Lee Ave
Oklahoma-city, OK
Ssm Health Care Of Oklahoma, Inc.

5.
Naji Karam MD

608 Nw 9th St
Oklahoma-city, OK
Saint Medical Group, Llc

6.
Ryan Norris

4221 S Western Ave
Oklahoma-city, OK
Integris Cardiovascular Physicians Llc

Providers in the same medical group

1.Jon Aagaard

2001 N Gary Ave
Wheaton Il 60187-3055
Family Practice

2.Matthew Aaker

8055 W Ave
Castle Hills Tx 78213-1842
Optometry

3.Justin Aaker

3613 Williams Dr
Georgetown Tx 78628-1373
Ophthalmology

4.Mohammad Aalai

7005 35th Ave
Jackson Heights Ny 11372-3970
Physical Medicine And Rehabilitation

5.Carol Aalbers Cp

4560 S Carson St
Carson City Nv 89701-6915
Clinical Psychologist

6.Hina Aamir

602 S Atwood Rd
Bel Air Md 21014-4323
Psychiatry